Mr. Speaker, in 2012 the U.S. banned generic OxyContin in favour of the tamper-proof OxyNEO. Provincial health officers, provincial health ministers, and the U.S. attorney general asked the current government to do the same thing. Instead, it gave the production okay to six companies.
Oxy addiction is the fastest-growing opioid addiction in North American. Increased border traffic of OxyContin has prompted U.S. senators to renew their appeal to the current government.
Will the new Minister of Health undo the damage and ban Canadian production of OxyContin?